One study showed that expression of the cytokine oncostatin M is increased in inflamed sites of the mucosa of patients with Crohn’s disease and ulcerative colitis; it also revealed that a high level of oncostatin M expression prior to treatment is associated with the failure of anti-TNF therapy [202]. This evidence concerns the gene OSM and Crohn disease.